Psychometric validation of the Psoriasis Symptom Diary using Phase III study data from patients with chronic plaque psoriasis
International Journal of Dermatology2015Vol. 55(3), pp. e147–55
Citations Over TimeTop 24% of 2015 papers
Bruce Strober, Yang Zhao, Mary Helen Tran, Ari Gnanasakthy, Judit Nyirady, C. Papavassilis, Lauren Nelson, Lori McLeod, Margaret Mordin, Alice B. Gottlieb, Boni E. Elewski, Mark Lebwohl
Abstract
The PSD is reliable, valid, and responsive, and represents a valid tool to enhance treatment decisions in patients with moderate to severe plaque psoriasis.
Related Papers
- → Intramuscular Alefacept Improves Health-Related Quality of Life in Patients with Chronic Plaque Psoriasis(2003)93 cited
- → Dermatology Life Quality Index in Patients with Psoriasis Treated with Biologic Versus Non-biologic Treatment in Malaysia: A Retrospective Cross-Sectional Study(2023)5 cited
- → DLQI as a major criterion for introduction of systemic agents in patients with mild psoriasis(2016)21 cited
- → Quality of life in children with psoriasis: results from a monocentric study.(2021)6 cited
- → Quality of life in children with psoriasis: results from a monocentric study(2021)5 cited